Influence of the route of administration on targeting of ovarian cancer with the chimeric monoclonal antibody MOv18: i.v. vs. i.p. (Q43560570)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Influence of the route of administration on targeting of ovarian cancer with the chimeric monoclonal antibody MOv18: i.v. vs. i.p. |
scientific article |
Statements
1 reference
Influence of the route of administration on targeting of ovarian cancer with the chimeric monoclonal antibody MOv18: i.v. vs. i.p. (English)
1 reference
I van Zanten-Przybysz
1 reference
C F Molthoff
1 reference
J C Roos
1 reference
R H Verheijen
1 reference
A van Hof
1 reference
M R Buist
1 reference
H M Prinssen
1 reference
W den Hollander
1 reference
P Kenemans
1 reference
1 April 2001
1 reference
1 reference
92
1 reference
1
1 reference
106-114
1 reference
Identifiers
1 reference
1 reference